Medpace (MEDP) — insider trading
Health Care · NASDAQ
Medpace (MEDP) has 17 reported SEC Form 4 insider transactions in our data, including 1 open-market sale among the most recent 17 (latest 2026-06-30).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-06-30 | Carley Brian T | Director | Option exercise / conversion (derivative) | 36 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Carley Brian T | Director | Option exercise / conversion | 36 | — | — | Form 4 |
| 2026-06-30 | Kraft Robert O. | Director | Option exercise / conversion (derivative) | 33 | $0.00 | $0 | Form 4 |
| 2026-06-30 | Kraft Robert O. | Director | Option exercise / conversion | 33 | — | — | Form 4 |
| 2026-06-30 | McCarthy Cornelius P. III | Director | Option exercise / conversion (derivative) | 28 | $0.00 | $0 | Form 4 |
| 2026-06-30 | McCarthy Cornelius P. III | Director | Option exercise / conversion | 28 | — | — | Form 4 |
| 2026-05-28 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Option exercise / conversion (derivative) | 16,349 | $0.00 | $0 | Form 4 |
| 2026-05-28 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Open-market sale | 16,349 | $450.00 | $7.36M | Form 4 |
| 2026-05-28 | EWALD STEPHEN P | Officer (General Counsel & Corp. Secy.) | Option exercise / conversion | 16,349 | $138.87 | $2.27M | Form 4 |
| 2026-05-15 | Carley Brian T | Director | Grant / award / vesting (derivative) | 1,110 | $0.00 | $0 | Form 4 |
| 2026-05-15 | DAVENPORT FRED B JR | Director | Grant / award / vesting (derivative) | 1,110 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Gwadry-Sridhar Femida H. | Director | Grant / award / vesting (derivative) | 1,110 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Kraft Robert O. | Director | Grant / award / vesting (derivative) | 1,110 | $0.00 | $0 | Form 4 |
| 2026-05-15 | McCarthy Cornelius P. III | Director | Grant / award / vesting (derivative) | 1,110 | $0.00 | $0 | Form 4 |
| 2026-05-15 | Zander Dani S. | Director | Grant / award / vesting (derivative) | 1,110 | $0.00 | $0 | Form 4 |
| 2026-04-24 | Troendle August J. | Director, Officer (CEO), 10% owner | Grant / award / vesting (derivative) | 10,000 | $0.00 | $0 | Form 4 |
| 2026-04-24 | Troendle August J. | Director, Officer (CEO), 10% owner | Grant / award / vesting (derivative) | 20,000 | $0.00 | $0 | Form 4 |
Ask the chat about MEDP's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Medpace (MEDP).
Last updated 2026-06-30 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.